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vFGFThe Autographa californica M nucleopolyhedrovirus (AcMNPV) viral ﬁbroblast growth factor (vFGF) has
functional parallels to cellular FGFs. Deletion of the AcMNPV vfgf has no obvious phenotype in cell
culture but delays the time of insect death. Here, we determined vFGF production during virus infection.
vFGF was detected at 24 hours post infection and through the remainder of the infection cycle. Since
vFGF is thought to be a secreted membrane-binding protein and virions acquire an envelope derived
from the cell membrane, we examined virions for the presence of vFGF using microscopy, ﬂow
cytometry, and afﬁnity chromatography. We found that vFGF associated with virions. Furthermore,
budded virus carrying vFGF had more afﬁnity to heparin than vFGF-deﬁcient budded virus, consistent
with the afﬁnity of FGFs for heparan sulfate proteoglycans. Although the function of virion-associated
vFGF is not clear, we found that virion-associated vFGF stimulated cell motility and affected virus
attachment.
© 2009 Elsevier Inc. All rights reserved.Introduction
Fibroblast growth factors (FGFs) are a family of growth factors that
play diverse roles in both embryonic development and homeostatic
maintenance (Ornitz and Itoh, 2001). Members of this family include
22 vertebrate homologs and several well-characterized invertebrate
orthologs, including Drosophila branchless, pyramus, and thisbe FGFs
(Samakovlis et al., 1996; Stathopoulos et al., 2004). FGFs are typically
secreted from the cell using the endoplasmic reticulum–Golgi
pathway. On the surface of cells, FGFs bind to heparan sulfate
proteoglycans through ionic interactions between the highly sulfated
oligosaccharides and the basic amino acids of FGFs (Faham et al.,
1996; Kreuger et al., 2005; Lin et al., 1999; Ornitz, 2000). The binding
of the growth factor to heparin sulfate serves to both protect FGF in
the extracellular environment from degradation and mediate down-
stream speciﬁcity with potential cellular receptors though differences
in the sugar sulfation patterns (Harmer, 2006; Raman et al., 2002).
Release of the heparan sulfate–FGF signaling complex from the cell is
mediated by factors such as heparanase or matrix metalloproteinase 2
which cleave the oligosaccharide chain from its membrane-bound
protein anchor (Plotnikov et al., 1999; Szebenyi and Fallon, 1999;
Vlodavsky and Friedmann, 2001; Tholozan et al., 2007). Once
released, heparan–FGF complexes can bind tyrosine kinase ﬁbroblast
growth factor receptors (FGFR) through interactions between amino
acids in the beta trefoil domain of FGF and the D2 extracellular domain
of the receptor (Mohammadi et al., 2005a,b; Ornitz, 2000). Binding of
a ligand with the extracellular domain of FGFR induces a conforma-ll rights reserved.tional change in the transmembrane region of the receptor, allowing
receptor homodimerization (Peng et al., 2009). Dimerization of the
FGFRs leads to transphosphorylation of intracellular kinase domains
and activation of the Ras–mitogen activated protein kinase signal
cascade pathway (Ornitz and Itoh, 2001; Pye and Gallagher, 1999;
Sutherland et al., 1996). The ﬁnal outcome of this activation varies
greatly, depending upon the ligand, receptor, and context of the signal
but can include induction of motility, cell proliferation, or differen-
tiation (Ornitz and Itoh, 2001).
In addition to vertebrate and invertebrate FGFs, most baculo-
viruses also encode FGF orthologs with sequence identity to cellular
FGFs (Detvisitsakun et al., 2005; Katsuma et al., 2004; Sutherland et
al., 1996). The best characterized baculovirus, Autographa californica
M nucleopolyhedrovirus (AcMNPV), encodes a single fgf that predicts
a 181-amino acid protein with a deﬁned and functional signal
sequence (Detvisitsakun et al., 2005; Katsuma et al., 2004). AcMNPV
vfgf expressed from a plasmid vector was secreted from cells and
had strong afﬁnity to heparin–Sepharose (Detvisitsakun et al., 2005).
The speciﬁc role of vFGF in viral pathogenesis has not been
deﬁned, but evidence suggests that it may aid in the trafﬁcking of
the virus frommidgut cells, the primary site of infection, to the tissues
in the hemocoel (Detvisitsakun et al., 2007). vFGF may also be
involved in hemocyte-mediated infection spread within insect tissues
(Detvisitsakun et al., 2005; Katsuma et al., 2008).
Previous studies using Northern blot analysis and RT–PCR detected
vfgf transcripts between 3 and 72 hours (h) post infection (p.i.)
(Detvisitsakun et al., 2005; Katsuma et al., 2004); however, the
production of vFGF during virus replication has not been determined.
This study shows timing of vFGF production during infection, its
secretion fate, and in vitro assays that suggest a function during virus
infection of susceptible hosts.
153C.J. Lehiy et al. / Virology 395 (2009) 152–160Results
Transcription of vfgf has been previously examined; vfgf was
classiﬁed as an early gene since transcription was evident at early
times p.i. and in the presence of cycloheximide (Detvisitsakun et al.,
2005; Katsuma et al., 2004). However, protein production kinetics has
not been reported during the infection cycle. To examine vFGF
accumulation during infection, we constructed a bacmid expressing
vfgf with a hemagglutinin (HA) tag at the C terminus to facilitate
immunodetection. Brieﬂy, 448 base pairs of vfgf (∼82% from the N
terminus) were replaced via homologous recombination with the
zeocin resistance gene using the commercially available bacmid
bMON14272. The enhanced green ﬂuorescent protein gene (egfp)
under the Drosophila heat shock protein (hsp) 70 promoter control, a
high-level inducible promoter in insect cells, and the polyhedrin
(polh) gene under polh promoter control were introduced into the
polh locus of bMON14272, resulting in AcBAC-vfgfKO (Detvisitsakun
et al., 2006). To construct AcBAC-vfgfHARep virus, egfp and polh
cassettes, and the HA-tagged vfgf under the control of its own
promoter was inserted in AcBAC-vfgfKO, so that only one copy of the
gene was present (Fig. 1A). The vfgf promoter, a 207-base pair
fragment, has been previously shown to support vfgf expression
(Detvisitsakun et al., 2006; Lehiy, Blair, and Passarelli, unpublished
results). To construct a virus carrying vfgf driven by the Drosophila
hsp70 promoter, AcBAC-HSP70vfgfHA, the 207-base pair vfgf pro-Fig. 1. Construction of two recombinant baculoviruses expressing a hemagglutin (HA)-tagg
tagged vfgf under the control a 207-base pair native promoter element was inserted into the
and the polh gene. To construct a recombinant virus with vfgf under heat shock (hsp) 70 p
Drosophila hsp 70 protein promoter. Conﬁrmation of the transposition site was veriﬁed by
was conﬁrmed using RT–PCR at various hours (h) post infection (p.i.) and vfgf-speciﬁc prim
SF-21 cells were infected with AcBAC, AcBAC-vfgfHARep or AcBAC-HSP70vfgfHA at an MOI o
infectious virus present was determined.moter fragment was replaced with the Drosophila hsp70 promoter.
The presence of vfgf and its correct insertion location within the viral
genome was conﬁrmed using PCR (results not shown). RT–PCR was
used to ensure that vfgf was expressed in AcBAC-vfgfHARep. We
detected vfgf transcripts at 6, 12, 24, and 48 h p.i. (Fig. 1B); AcBAC-
vfgfRep virus, expressing untagged vfgf from the same promoter, also
expressed vfgf transcripts (Detvisitsakun et al., 2006). Although it is
possible that vfgf is better expressed at its native locus, this 207-base
pair vfgf promoter region was sufﬁcient to repair phenotypic defects
in AcBAC-vfgfKO (Detvisitsakun et al., 2006).
To evaluate whether insertion of vfgf under either native or hsp70
promoter control in AcBAC-vfgfHARep and AcBAC-HSP70vfgfHA,
respectively, affected virus replication, we performed single-step
growth curve analyses. SF-21 cells were infected with either AcBAC-
vfgfHARep, AcBAC-HSP70vfgfHA or AcBAC, a virus in which vfgf has
not been perturbed, at a multiplicity of infection (MOI) of 5 plaque-
forming units (PFU)/cell, supernatant was collected at several times
p.i., and the titer determined by TCID50. We did not detect any
signiﬁcant growth differences between the viruses throughout the
time course of infections (Fig. 1C).
We determined accumulation of vFGF driven by its native
promoter by infecting TN-368 cultured cells at an MOI of 5 PFU/cell
with either AcBAC-vfgfHARep or AcBAC-HSP70vfgfHA and immuno-
detection. vFGF steady-state levels were observed in immunoblots
with whole cell lysates prepared from AcBAC-vfgfHARep-infecteded vfgf. (A) Using an AcMNPV bacmid template lacking a functional vfgf gene, an HA-
polyhedrin (polh) locus along with an enhanced green ﬂuorescent protein (egfp) gene
rotein promoter control, the 207-base pair promoter element was replaced with the
PCR (results not shown). (B) Transcription of vfgf under its native promoter control
ers. (C) One-step growth curve analysis of AcBAC-vfgfHARep and AcBAC-HSP70vfgfHA.
f 5 PFU/cell. At the indicated hour p.i., the supernatant was collected and the amount of
Fig. 2. Production of vFGF during virus infection. Intracellular (A) and extracellular (B) production of vFGF from TN-368 cells infected with AcBAC-vfgfHA (vFGFHA) or AcBAC-
HSP70vfgfHA (HSP70 VFGFHA) at anMOI of 10 PFU/cell. Cells were lysed at the times (hours, h) post infection (p.i.) indicated at the top and total protein levels were quantiﬁed using
the BioRAD Protein Assay (BioRAD). Lanes with vFGFHA lysates have 25-fold more total protein compared to HSP70 vFGFHA lanes. After transfer to a PVDF membrane, the samples
were immunoblotted using anti-HA antibody. Integrated densitometry values (IDVs) for each lane, normalized to background levels are reported at the bottom of each panel. NA, not
applicable, equivalent to background levels.
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not shown). Despite numerous attempts, vFGF could not be detected
in the supernatant of AcBAC-vfgfHARep-infected cells (Fig. 2B).
AcBAC-HSP70vfgfHA-infected cells, as expected, exhibited much
higher levels of vFGF accumulation starting at 12 h p.i., peaking at
24 h p.i. and continuing at 48 h p.i., even though 25-fold less total
protein was loaded per lane than in the lanes with AcBAC-vfgfHARep
cell lysate (Fig. 2A). vFGF was also detected in the supernatant of
AcBAC-HSP70vfgfHA-infected cells, suggesting vFGF was efﬁciently
secreted and released from cells (Fig. 2B). It is possible that the
inability to detect vFGF in the medium of AcBAC-vfgfHARep-infected
cells, where vfgf expression is lower than from AcBAC-HSP70-vfgfHA-
infected cells, was due to protein detection sensitivity levels. As a
signaling molecule, the necessary levels of vFGF for efﬁcient function
do not need to be high.
We detected vFGF in whole cell lysates and in cell culture media
when expressed at high enough levels. When expressed at lower
levels, vFGF secretion may be hard to detect. In addition, the presence
of vFGF in whole cell lysates could be due to secreted vFGF tethered to
the surface of cells by heparan sulfate proteoglycan interactions or its
presence intracellularly. To validate that vFGF was cell surface-bound,
SF-21 cells were infected with AcBAC-HSP70vfgfHA and harvested
24 h p.i. Infected cells were ﬁxed and immunolabeled with anti-HA
antibody followed by a gold-labeled secondary antibody prior to
embedding in resin. Dense pockets of gold-labeled antibodies,
corresponding to cell surface-bound vFGF, were evident on cells,
conﬁrming that vFGF was indeed secreted and retained on the surface
of cells (Fig. 3A).
To further strengthen the observation that vFGF binds to cell
membranes and have a quantitative comparison of cell-bound vFGF
from each virus construct, TN-368 cells were infected with AcBAC-
HSP70vfgfHA, AcBAC-vfgfHARep, or AcBAC-vfgfKO and harvested at
12, 24, and 48 h p.i. After harvesting, cell surfaces were immunola-
beled with anti-HA primary antibody and an allophycocyanin (APC)-
conjugated secondary antibody, and labeled cells were analyzed using
ﬂuorescence-based ﬂow cytometry. The number of vFGF-positive cells
was considerably higher in AcBAC-HSP70vfgfHA- than AcBAC-
vfgfHARep-infected cells at all time points examined, although with
both AcBAC-HSP70vfgfHA and AcBAC-vfgfHARep infections, the
number of vFGF-positive cells increased approximately 5.4- to 6-fold between 12 and 24 h p.i., respectively (Fig. 4). Only background
levels of antibody were bound to the cell surfaces of AcBAC-vfgfKO-
infected cells at all time points.
We predicted that if vFGF was secreted from cells and bound to
heparan sulfate proteoglycans on cell membranes, virions budding
from cells would acquire heparan sulfate-bound vFGF on their
envelopes. To examine if budded virions incorporated vFGF on the
virus particle, budded virions from AcBAC-vfgfKO-, AcBAC-
vfgfHARep-, or AcBAC-HSP70vfgfHA-infected SF-21 cells were puri-
ﬁed by gradient centrifugation, ﬁxed onto Nickel Formvar/Carbon
200 mesh grids, and vFGF was detected using immunoelectron
microscopy. Gold-labeled particles speciﬁc to HA-tagged vFGF were
detected on AcBAC-vfgfHARep virions (Fig. 3B); however, these were
absent in AcBAC-vfgfKO virions, indicating speciﬁcity (Fig. 3D). In the
majority of experiments, we could only detect three or less gold-
labeled particles on individual vFGF-HA carrying virions. In contrast,
there were over 10-fold more gold-labeled particles conjugated to
anti-GP64 that associated with GP64, an envelope associated viral
protein essential for virus entry (Fig. 3C). Interestingly, the gold-
labeled vFGF-HA particles were usually localized at one end of the
virion. Virions derived from the AcBAC-HSP70vfgfHA-infected cells
showed increased gold-labeled particles also at the bulbous end of the
virion, reafﬁrming the polarization of virions and vFGF (Fig. 3E).
Since FGFs, including vFGF, have high afﬁnity to heparin–
Sepharose, we next compared the afﬁnity of AcBAC-vfgfHARep,
AcBAC-vfgfKO and AcBAC-HSP70vfgfHA puriﬁed virions to heparin–
Sepharose and determined whether the presence or absence of vFGF
on the virus surface affected this property. Equal numbers of
infectious virions, calculated prior to use by TCID50, were incubated
with heparin–Sepharose beads, sulfated and carboxylated glucosami-
noglycans on Sepharose that yield an overall negative charge and
serve as a cation exchangers. To reduce non-speciﬁc interactions, the
beads were washed with 125 mM NaCl to disrupt ionic interactions
prior to eluting the bound proteins with a 1.25 M NaCl solution. All
fractions were dialyzed against TC-100 incomplete media and virus
solutions were titered. We found that dialysis was necessary since
high salt concentrations used during washes and elution interfered
with infections (Lehiy and Passarelli, unpublished results). AcBAC-
vfgfKO virions had less afﬁnity to heparin–Sepharose than either
AcBAC-vfgfHARep or AcBAC-HSP70vfgfHA virions, with the majority
Fig. 3. Presence of vFGF on the surface of cells and budded virions. (A) SF-21 cells were infected with AcBAC-HSP70vfgfHA at a MOI of 5 PFU/cell. At 24 h p.i., cells were ﬁxed and
immunolabeled with anti-HA.11 primary antibody and a gold-conjugated secondary antibody. After embedding, cells were examined for the presence of vFGF on the cell surface.
vFGFHA was detected in dense pockets denoted by the dark gold label. (B–D) SF-21 cells were infected with AcBAC-vfgfHARep (B, C), AcBAC-vfgfKO (D), or AcBAC-HSP70vfgfHARep
(E) at an MOI of 0.1 PFU/cell, and virions were isolated by high-speed centrifugation using either sucrose or NycoPrep™ gradients. Virus particles were labeled with anti-HA.11
antibody (B, D, E) or anti-GP64 antibody (C) and a gold-conjugated secondary antibody. Individual virions were visualized using a Philips MC-100 transmission electron microscope.
The images are representative of the ﬁndings from 3 independent experiments. Bars represent 0.1 μm.
155C.J. Lehiy et al. / Virology 395 (2009) 152–160of virions eluting in the unbound fraction, ﬂow-through, and wash
fractions. In contrast, virions with vFGF on the surface had higher
afﬁnity to heparin beads, eluting mainly in the presence of high salt
concentrations (Fig. 5). Non-speciﬁc virus binding to heparin–
Sepharose can be attributed to either cellular FGFs incorporated on
the viral envelopes, FGFs from the serum containing media, or other
ionic interactions.Fig. 4. TN-368 cells were infected at a MOI of 5 PFU/cell with either AcBAC-vfgfHARep,
AcBAC-vfgfKO, or AcBAC-HSP70vfgfHA. At 24 and 48 h p.i., the cells were harvested and
resuspended in PBS, pH 6.2. The surface of cells was labeled with anti-HA, a 1:1000
dilution of antibody with PBS, and an APC-conjugated secondary antibody. Labeled cells
were analyzed for APC ﬂuorescence using a FACSCalibur ﬂow cytometer. The number of
cells reported as APC-positive is from a total of 10,000 cells counted (⁎⁎⁎pb0.05).It has previously been demonstrated that heparin–Sepharose
puriﬁed vFGF stimulates motility of insect cells by stimulating an
FGFR and ensuing a subsequent signaling cascade (Detvisitsakun et
al., 2005; Katsuma et al., 2006a,b); thus, we asked whether virions
containing vFGF could stimulate cell motility. Using transwells withFig. 5. Binding of budded virions to heparin–Sepharose beads. Puriﬁed virions from
either AcBAC-vfgfHARep, AcBAC-vfgfKO, or AcBAC-HSP70vfgfHA-infected SF-21 cells
were incubated with heparin–Sepharose beads. The beads were washed with a salt-
containing solution to remove non-speciﬁc binding and then with a 1.25 M NaCl
solution. After dialysis, the ﬂow-through, wash, and elution fractions were dialyzed to
remove excess salt and the infectious virus titered. Virus in the ﬂow-through and wash
fractions was combined and is represented in the unbound columns. The elution
fraction represents the amount of virus that remained bound to the column after
washing (⁎⁎⁎pb0.05).
156 C.J. Lehiy et al. / Virology 395 (2009) 152–160polycarbonate membrane inserts, 2×104 SF-21 cells were placed in
the upper chamber while 1×105 to 1×107 infectious puriﬁed AcBAC-
HSP70vfgfHA or AcBAC-vfgfKO virions were placed in the lower
chamber. After 4 h, the transwell inserts were removed and cells that
migrated to the lower chamber were quantiﬁed using CellTiter-Glo
luminescent substrate that measures ATP production and is indicative
of live cells. Cell migration increased proportionally to virus titer with
1×107 virions yielding statistically signiﬁcant differences between
the three viruses (Fig. 6A). To address whether vFGF cleaved from the
virion induced motility, we treated 1×107 puriﬁed AcBAC-
HSP70vfgfHA virions with 1 IU of heparinase III, an enzyme known
to cleave heparan sulfate proteoglycans from cellular surfaces. After
treatment, the virion and supernatant fractions were used in cell
motility experiments. Cell motility stimulated by heparinase III-
treated virions decreased compared to untreated virions, while the
supernatant fraction containing cleaved vFGF stimulated cell motility
(Fig. 6B). This suggests a possible function for the virion-associated
vFGF, but this function needs to be conﬁrmed during infection.Fig. 6. Virus-induced cell migration. (A) SF-21 cells (2×104) were placed in the upper
chamber of a migration chamber with an 8 μm pore size, and puriﬁed infectious virions
from AcBAC-vfgfHARep, AcBAC-vfgfKO, or AcBAC-HSP70vfgfHA were placed in the
lower chamber. After 4 h of incubation at 27 °C, the upper chamber was removed and
the number of cells that migrated to the lower chamber was determined using
CellTiter-Glo Luminescent Assay. (B) AcBAC-HSP70vfgfHA virions were treated with
heparinase III to release vFGF–heparan complexes from the virus envelope. Heparinase
III-released vFGF into the supernatant or heparinase III-treated and -untreated virions
were used in motility assays (⁎⁎⁎pb0.05).vFGF is a membrane-associated protein that interacts with other
membrane proteins, including heparan sulfate proteoglycans and the
FGFR. In addition, a number of viruses belonging to several virus
families, use heparan sulfate molecules as their receptors (Flint et al.,
2004). Thus, we were interested in evaluating whether the presence
or absence of vFGF on the surface of the virions affected virus
attachment to and/or entry into permissive insect cells. To this end,
virions from AcBAC-vfgfHARep, AcBAC-vfgfKO, and AcBAC-
HSP70vfgfHA were radiolabed with 35S-methionine and partially
puriﬁed to remove unbound radioactivity. Radiolabeled AcBAC-
vfgfHARep, AcBAC-vfgfKO, or AcBAC-HSP70vfgfHA was added at an
MOI of 1 PFU/cell to chilled SF-21 or TN-368 cells. At speciﬁc times
post attachment, the virus supernatant (i.e., unattached virions) was
removed, and the cells were washed three times with cold PBS. After
washing, the cells were lysed, and the radioactivity was determined in
a scintillation counter. SF-21 cells treated with AcBAC-vfgfKO bound
less radioactive particles than AcBAC-HSP70vfgfHA and AcBAC-
vfgfHARep at every time point measured (Fig. 7A). Similar defects
were observed using TN-368, although the binding defects of AcBAC-
vfgfKO compared to viruses encoding vfgf were not as marked as
those in SF-21 cells, and differences were not signiﬁcant 30 minutes
post attachment (Fig. 7B). We repeated the binding assay at 25 °C
using SF-21 cells and also observed a defect in attachment at this
temperature, which was more prominent with shorter attachment
times (Fig. 7C).
To determine whether the presence of vFGF on the budded virus
envelope affected entry, we inhibited endosomal acidiﬁcation, a step
required for endosomal membrane fusion, with ammonium chloride
at several time points after AcBAC-vfgfRep or AcBAC-vfgfKO attach-
ment to SF-21 cells (Hefferon et al., 1999). At early times post
attachment (0 through 20 minutes), treatment of cells with
ammonium chloride resulted in an entry defect ranging between
24.6% and 34.5% for AcBAC-vfgfKO-compared to AcBAC-vfgfHARep-
infected cells (Fig. 7D). At 30 and 60 minutes post attachment,
treatment of AcBAC-vfgfKO-infected cells with ammonium chloride
resulted in an entry defect of 15.9% and 14.1%, respectively, compared
to AcBAC-vfgfHARep. AcBAC-vfgfRep- and AcBAC-vfgfKO-infected but
ammonium chloride-untreated cells showed no signiﬁcant differ-
ences (Fig. 7D, control column). Although we observed entry
differences between AcBAC-vfgfHARep and AcBAC-vfgfKO, they
were too small to infer any signiﬁcance during the normal virus
attachment and entry phase.
Discussion
The role of secreted vFGF during virus infection has been
hypothesized; it may stimulate tracheoblast motility during second-
ary infections or hemocyte chemotaxis during systemic infection
(Detvisitsakun et al., 2005; Katsuma et al., 2008). Since its speciﬁc role
has not been deﬁned in vivo, it is important to determine at what time
during the replication cycle is vFGF produced as well as the
destination of the secreted product. This information will provide
insight into functions of vFGF during the infection cycle in vitro and in
vivo.
In this study, we observed that AcBAC-vfgfHA-infected TN-368
cells produced HA-tagged vFGF at 24 and 48 h p.i. This is consistent
with vfgf transcripts previously detected starting at 3 h p.i. and in the
presence of cycloheximide, and at late times, as part of multicistronic
messages (Detvisitsakun et al., 2005). The inability to detect vFGF
earlier or in the supernatant of infected cells is not surprising, since as
a signaling ligand, vFGF would be required in concentrations under
5 ng/ml to induce activation of target cells (Detvistsakun, Wu, and
Passarelli, unpublished results; Katsuma et al., 2006a). Since vFGF is
secreted during virus infection of cells and probably binds cell surface
heparan sulfated proteoglycans in vivo, we considered that as the
budded virus exited from infected cells, its envelope would acquire
Fig. 7. Virus attachment and entry into SF-21 and TN-368 cells. 35S-methionine radiolabeled AcBAC-vfgfHARep, AcBAC-vfgfKO, or AcBAC-HSP70vfgfHA virions (MOI of 1 PFU/cell)
were allowed to attach to SF-21 (A, C) or TN-368 (B) cells at either 4 °C (A, B) or 25 °C (C) for the speciﬁc times (in minutes) indicated at the bottom of each graph. After attachment,
the virus supernatant was removed and cells washed 3 times prior to harvesting. Radioactivity (CPM) in the cell lysate was determined in a scintillation counter. To normalize all
samples, the CPM counts on all samples were adjusted relative to initial CPM counts. (D) To determine vFGF effects on virus entry, AcBAC-vfgfHARep or AcBAC-vfgfKO virions (MOI of
1 PFU/cell) were allowed to attach to SF-21 cells for 60 minutes at 4 °C. Virus supernatant was removed, and cells were washed and resuspended in TC-100 complete media. Exit from
the endosome was inhibited by the addition of ammonium chloride at speciﬁc times post attachment (in minutes) or left untreated (Control) as indicated at the bottom of the graph.
At 24 h post attachment, eGFP expression was determined using ﬂow cytometry.
Fig. 8. Proposed model of vFGF secretion and its presence on the surface of the budded virions. vFGF (ﬁlled circle) is secreted from the cell during the infection cycle (1) and binds to
heparan sulfate proteoglycans (HSPG) on the cell surface (2). As budded virions exit the cell, they acquire the cellular membrane (open circles) (3), including the heparan sulfate
proteoglycan–vFGF complexes. After release, the mature infectious virion retains vFGF (4).
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158 C.J. Lehiy et al. / Virology 395 (2009) 152–160vFGF–heparan sulfate proteoglycan complexes along with other
cellular and viral membrane proteins (Fig. 8). Therefore, we
investigated this possibility and found that vFGF was present on the
cell surface of infected cells and that budded virus carried vFGF.
Furthermore, the presence of vFGF affected the afﬁnity of virions to
bind heparin–Sepharose in vitro. Our studies were performed using
two insect cell lines, SF-21 and TN-368, since viruses lacking vfgf have
effects on both species from which the cells were derived (Detvi-
sitsakun et al., 2007; Katsuma et al., 2006b).
Potential roles for vFGF on the surface of the virion are open to
speculation, although this study provides some evidence suggesting
chemotaxis of target cells may be involved. Motility of cells towards
the virus would facilitate virus spread. This is consistent with viruses
carrying vfgf, accelerating host mortality (Detvisitsakun et al., 2007;
Katsuma et al., 2006b). Alternatively, the bona ﬁde properties of FGF
secretion may causally localize vFGF on the surface of cells and thus,
the virus envelope. Studies addressing the function of vFGF on the
membrane of virus particles during infection of the host may clarify its
in vivo role.
Other viruses use cell surface heparan sulfate proteoglycans for
entry into cells. Proteins on the surface of the human herpes virus
8 interact with sulfated heparan as a tether prior to glycoprotein-
mediated cell adhesion and entry (Akula et al., 2001; Spear, 2004;
Wang et al., 2001). In addition, herpes simplex 1 virus uses heparan
sulfate to bind to the basal laminae of mucocutaneous tissues prior to
entry (Yura et al., 1992). We showed that the presence of vFGF on the
surface of the virion facilitates virus attachment more efﬁciently
possibly via interaction with surface heparan sulfate proteoglycans or
FGFRs; however, it is not clear if these effects are signiﬁcant during in
vivo infections. Interestingly, transduction of mammalian cells with
baculoviruses also shows a robust dependency on virus–heparin
interactions but not on other negatively charged polyanions such as
chondroitin sulfate or dermatan sulfate (Duisit et al., 1999). It is
tempting to speculate that the afﬁnity of vFGF and heparin enhances
the electrostatic interactions between the virus and the cell surface,
allowing more efﬁcient virus attachment, but the signiﬁcance of this
effect during infection is not clear.
Materials and methods
Cells, viruses, and insects
The cell line IPLB-SF-21 (SF-21) (Vaughn et al., 1977) derived from
the fall armyworm, Spodoptera frugiperda, and TN-368 cells (Hink,
1970) derived from the cabbage looper, Trichoplusia ni, were
maintained in TC-100 medium (Invitrogen) supplemented with 10%
fetal bovine serum (Atlanta Biological) and 0.26% tryptose broth as
described previously (O'Reilly et al., 1994).
Transplacement vector construction
We constructed a transfer vector to generate a recombinant of
AcMNPV expressing vfgf under native promoter control. First, the
oligonucleotides (Sac I-F 5′-CTTAAGTCTGCAGTTTTAC-3′ and Sac 1-R
5′-ATAAAAATGTTTTTATTGTAAAATACAC-3′) were used to amplify an
863-base pair fragment from a construct containing HA-tagged vfgf
and ﬂanking regions. DNA containing HA-tagged vfgf and a 207-base
pair region upstream of vfgf that serves as a promoter region was
ligated into the transplacement vector pFastBac−polh+gfp+ (Detvi-
sitsakun et al., 2006) at Sac I sites to generate pFastBac−polh+-
vFGFHA-gfp+. The correct ampliﬁed sequence was veriﬁed by
nucleotide sequencing analysis. To create the transplacement vector
with vfgf under Drosophila heat shock protein (hsp) 70 promoter
control, the 207-base pair native promoter element was removed and
the 739-base pair hsp 70 promoter element was inserted. The correct
insertion was also veriﬁed by nucleotide sequencing analysis.Construction of AcBAC-vfgfHARep and AcBAC-HSP70vfgfHA
AcBAC-vfgfHARep and AcBAC-HSP70vfgfHA were generated by
Tn7-mediated transposition by transformingMAXDH10Bac Efﬁciency
competent Escherichia coli (Invitrogen) with pFastBac−polh+-
vFGFHA-gfp+ or pFastBac−polh+-HSP70 vFGFHA-gfp+. Bacterial
cells were incubated for 4 h in SOC media (Invitrogen) at 37 °C and
then plated on the appropriate selection media and incubated for an
additional 18 h according to the Bac-to-Bac Baculovirus Expression
System Manual (Invitrogen). White colonies resistant to kanamycin
and gentamicin were selected, and the transposition event and
ﬂanking regions were veriﬁed by PCR analysis. Budded virus was
produced by transfection of AcBAC-vfgfHARep or AcBAC-
HSP70vfgfHA DNA into SF-21 cells by liposome-mediated transfection
as previously described (Crouch and Passarelli, 2002).
Virus growth curves and RT
SF-21 cells were infected at an MOI of 5 PFU/cell with AcBAC-
vfgfHARep, AcBAC-HSP70vfgfHA or AcBAC. Budded virus was
collected at different times p.i. and titers were determined by TCID50
(O'Reilly et al., 1994). The graph represents three independent
experiments for each virus. Cells from theAcBAC-vfgfHARep infections
were harvested from plates, lysed with Trizol reagent (Invitrogen),
and stored at−80 °C until the entire time course was complete. Using
the standard protocol, total RNA from infected cells was extracted and
quantiﬁed. Aliquots (4 μg) from each time point were treated with
2 units of DNAse I for 2 h and then heat-inactivated at 72 °C for
15 minutes. After DNAse I treatment, the Access RT–PCR system
(Promega) was used to amplify vfgf-speciﬁc transcripts with 1 μg of
treated RNA as a template and oligonucleotides (F5′- GGAGCTGTT-
TACGGAACCATTG-3′ and R5′- CAGTGCCACATACGTCAACTTG-3′) as
primers. To control for DNA contamination, parallel samples lacking
AMV Reverse Transcriptase were tested. PCR conditions were carried
out at 45 °C for 1 h, followed by 40 cycles of 95 °C for 2 minutes, 45 °C
for 30 seconds, and 72 °C for 1 minute.
Immunoblotting
TN-368 cells (2×106) were infected at an MOI of 10 PFU/cell with
AcBAC-vfgfHARep or AcBAC-vfgfKO virus. At several times p.i., cells
were collected in 100 μl of Laemmli loading buffer. Proteins were
resolved in a sodium dodecyl sulfate–12% polyacrylamide gel,
transferred to a PVDF membrane, and detected using 1:3000 dilution
of anti-HA.11 antibody (Covance), 1:5000 dilution of goat anti-mouse
IgG–horseradish peroxidase (Bio-Rad). The SuperSignal West Femto
Maximum Sensitivity Substrate (Pierce) was used to detect cross-
reactive proteins. Densitometry integrated densitometry values
(IDVs) were calculated using AlphaImager 2200 software.
Transmission electron microscopy
SF-21 cells (2×108) were infected with AcBAC-vfgfHARep, AcBAC-
vfgfKO, or AcBAC-HSP70vfgfHA at an MOI of 0.1 PFU/cell. At 72 h p.i.,
cell supernatant was collected and budded virus isolated using
density gradient centrifugation (O'Reilly et al., 1994). Puriﬁed virions
were removed from sucrose or NycoPrep™ Universal (Axis Shield)
gradients and resuspended in PBS, pH 6.2 (Potter and Miller, 1980).
Virions (1:100 dilution) were bound to Nickel Formvar/Carbon 200
mesh grids (Ted Pella, Inc.) and immunolabeled with a 1:1500
dilution of anti-HA.11 antibody (Covance) or 1:1500 dilution of anti-
GP64 (AcV1) antibody (Santa Cruz Biotechnology) and 1:100 dilution
of anti-mouse IgG (whole molecule)–gold antibody (Sigma). Virions
were visualized with a Philips MC-100 transmission electron
microscope.
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TN-368 cells (0.5×106) were infected with AcBAC-vfgfHARep,
AcBAC-vfgfKO, or AcBAC-HSP70vfgfHA at an MOI of 5 PFU/cell. At 24
and 48 h p.i., cells were harvested, washed twice with cold PBS (pH
6.2), and then resuspended in 100 μl of 1:1000 dilution of anti-HA.11
antibody (Covance). After 1 h, the antibody solution was removed and
cells were washed once with PBS. Cells were then resuspended in
100 μl of 1:2000 dilution of APC-conjugated anti-mouse IgG antibody
(BD Biosciences) for 1 h in the dark. Unbound antibody was removed,
and the cells were washed 3 times in PBS before ﬁxing in 100 μl of 4%
paraformaldehyde–1% glutaraldehyde in 0.1 M PBS. Cells were
analyzed using a FACSCalibur ﬂow cytometer.
Heparin binding assay
SF-21 cells (2×108) were infected with AcBAC-vfgfHARep, AcBAC-
vfgfKO, or AcBAC-HSP70vfgfHA, and virions were isolated and titered
as described above (O'Reilly et al., 1994). Heparin Sepharose™ 6 Fast
Flow beads (Amersham Biosciences) were washed with and resus-
pended in PBS pH 6.2. Aliquots (100 μl) from a 50% bead slurry were
mixed with 5×107 infectious virions and then diluted to a ﬁnal
volume of 1 ml. The virus–heparin–Sepharose mixture was incubated
overnight at 4 °C with steady rotation. After binding, the ﬂow-through
was collected and the beads were washed with 1 ml of TC-100
incomplete media. Bound vFGF was eluted with 1.25 M NaCl solution
(1 ml). The input, ﬂow-through, wash, and elution fractions were
dialyzed in TC-100 incomplete media for a minimum of 4 h at 4 °C to
remove excess salt and maintain comparable salt concentrations in
the different samples. After dialysis, the amount of infectious virions
in each sample was determined by TCID50. Results are reported as a
percentage of the total viral infectious units present in each sample
treatment.
Transmigration assay
SF-21 cell migration was assessed using 8 μm pore size Costar
transwells with polycarbonate membrane inserts. Approximately
2×104 cells were loaded onto transwell inserts and allowed to settle
for 30 minutes. The transwell inserts were then transferred to 24-well
plates containing virus and incubated for 4 h at 27 °C. Puriﬁed
infectious virions (1×105 to 1×107) from AcBAC-vFGFHARep-,
AcBAC-HSP70vfgfHA-, or AcBAC-vfgfKO-infected cells were placed
in the lower transwell chamber along with 500 μl of PBS, pH 6.2. After
incubation, the transwell inserts were removed and cells that had
migrated downward were quantiﬁed using CellTiter-Glo luminescent
substrate to measure ATP, according to the protocol provided by the
manufacturer (Promega). The level of luminescence was determined
with the Wallac Victor3 1420 Multilabel counter (Perkin-Elmer). To
remove virion-bound vFGF, 3×107 AcBAC-HSP70vFGFHA virions in
3 ml of buffer (20mM Tris–HCl, pH 7, 0.1 mg/ml BSA, and 4 mMCaCl2)
were treated with 1 IU of heparinase III from Flavobacterium
heparinum (Sigma Aldrich) at 27 °C for 4 h. After treatment, virions
were puriﬁed by centrifugation at 24,000×g through a 25% NycoPrep
cushion. The supernatant and cushion were carefully removed, and
the pelleted virus was reconstituted with 1 ml of PBS, pH 6.2. In the
migration assay, 500 μl of clariﬁed supernatant and 1×106 AcBAC-
HSP70vfgfHA virions were used in cell motility assays.
Virus attachment assay
SF-21 cells (8×107) were infected at an MOI of 0.1 PFU/cell with
AcBAC-vfgfHARep, AcBAC-vfgfKO, or AcBAC-HSP70vfgfHA. The su-
pernatant was removed 29 h p.i. and replaced with Grace's Insect
Medium lacking L-methionine and unsupplemented (Invitrogen).
After 1 h, EasyTag™ EXPRESS 35S Protein Labeling Mix (Perkin Elmer)was added to a ﬁnal concentration of 10 μCi/ml and cells were
incubated at 27 °C for 10 h. Cells were then supplemented with
10 mM unlabeled methionine and 10% FBS and incubated for an
additional 48 h. After incubation, the supernatant was removed and
centrifuged at 1000×g for 5 minutes to remove any debris present.
The cleared supernatant was centrifuged at 80,000×g for 75 minutes
at 4 °C through a 25% sucrose cushion to pellet the virus and then
resuspended in 10 ml of TC-100 complete media supplemented with
10% FBS. The radiolabeled virus was titered in triplicate using TCID50
end point dilution methods, and radioactivity in the virus suspension
was measured by mixing 10 μl of virus with 1.5 ml of NET lysis buffer
(20mM Tris, 150 mMNaCl, 0.5% deoxycholate, 1% Nonidet P-40 1mM
EDTA, pH 7.5) and 3.5 ml of EcoLUME™ Liquid Scintillation ﬂuid (MP
Biomedicals). Cells (1×106) were plated on a 35-mm tissue culture
dish and allowed to attach for 1 h at 27 °C before placing at a 4 °C for
3 h. After chilling, the cells were placed on ice blocks, and the
supernatant was removed. Chilled virus was then added to each well
(MOI of 1 PFU/cell, 500 μl total volume) and removed at speciﬁc time
intervals (0, 5, 10, 20, 30, and 60minutes). Immediately after, the cells
were washed with 3 ml of ice-cold PBS, pH 6.2, and then lysed with
1.5 ml of NET buffer. The lysate was transferred to scintillation vials
along with 3.5 ml of EcoLUME™ Liquid Scintillation ﬂuid. Radioactiv-
ity was determined for 1 minute using a Beckman-Coulter LS6500
Scintillation counter. To normalize all samples, the CPM counts on all
samples were adjusted relative to initial CPM counts.
Endosomal acidiﬁcation assay
SF-21 cells (1×10 6) were allowed to attach for 1 h at 27 °C prior
to incubation at 4 °C for 2 h and infected at an MOI of 1 PFU/cell for
1 h at 4 °C with pre-chilled AcBAC-vfgfHARep or AcBAC-
HSP70vfgfHA. After 1 h, the virus supernatant was removed and
cells washed 3 times with pre-chilled PBS, pH 6.2. After washing, the
cells were treated with warm TC-100 complete media and returned
to a 27 °C incubator. At 0, 5, 10, 20, 30, and 60 minutes post
attachment, ammonium chloride was added to the wells (ﬁnal
concentration of 25 mM) to inhibit endosome acidiﬁcation. As a
control, a well of infected cells was left untreated allowing endosomal
acidiﬁcation to continue normally. Twenty-four hours post attach-
ment, the cells were removed from the plates, ﬁxed with 100 μl of 4%
paraformaldehyde–1% glutaraldehyde in 0.1 M PBS. Cells were
analyzed using a FACSCalibur ﬂow cytometer, and the results of
two independent experiments were shown here.
Analysis of data
Analysis of standard deviations and statistical signiﬁcance was
done using GraphPad Prism® software.
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